Serotonin and neuroplasticity - Links between molecular, functional and structural pathophysiology in depression
Christoph Kraus1, Eero Castrén2, Siegfried Kasper3
1NEUROIMAGING LABs (NIL) - PET & MRI & EEG & Chemical Lab Department of Psychiatry and Psychotherapy Medical University of Vienna.
Neuroscience and Biobehavioral Reviews
|March 27, 2017
Summary
Selective serotonin reuptake inhibitors may restore juvenile-like brain plasticity in adults with depression. Combining these treatments with other plasticity enhancers could improve major depressive disorder outcomes.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Serotonin and neuroplasticity are crucial for development and are implicated in depression.
- Selective serotonin reuptake inhibitors (SSRIs) can reactivate juvenile-like neuroplasticity.
Purpose of the Study:
- To bridge preclinical and clinical research on serotonin and neuroplasticity in major depressive disorder (MDD).
- To explore how SSRI-induced neuroplasticity changes can inform clinical antidepressant treatment.
Main Methods:
- Review linking preclinical findings with clinical studies in MDD.
- Analysis of structural magnetic resonance imaging (sMRI) data in patients and animal models.
- Examination of the role of developmental plasticity, synaptic serotonin, and neurogenesis.
Main Results:
- Dysfunctional developmental plasticity affects cognitive and emotional functions.
- SSRIs can reverse disease-state-specific gray matter reductions observed in MDD patients.
- Animal models suggest serotonergic neuroplasticity changes contribute to reduced neuronal density and hippocampal volume in depression.
Conclusions:
- SSRI treatment may reverse neuroplasticity deficits in MDD.
- Combining SSRIs with plasticity-enhancing interventions like ketamine, exercise, or learning may improve treatment efficacy for depression.
Related Concept Videos
Depression: Overview
1.1K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.1K
Long-term Depression
3.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.5K
Long-term Depression
33.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.5K
Depressive Disorders: Etiology
806
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
806
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
2.3K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.3K
Neuroplasticity
2.1K
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
2.1K


